New Delhi: Drug firm Suven Life Sciences reported 7.8 per cent increase in standalone net profit at Rs 40.06 crore for the fourth quarter ended March 2017.
The company had posted a net profit of Rs 37.16 crore during the same period of last fiscal, Suven Life Sciences said in a BSE filing.
Net sales of the company rose 3.3 per cent to Rs 174.99 crore during the quarter under review as against Rs 169.37 crore in the year-ago period.
For the entire fiscal, the company reported a consolidated net profit of Rs 87.18 crore. It had posted a net profit of Rs 71.84 crore in the 2015-16 fiscal.
Its net sales for the fiscal stood at Rs 539.16 crore as compared to Rs 500.28 crore in the year-ago period.
The company said its board has declared and paid an interim dividend of Re 1 per share for FY17.